News – Page 662 – Endpoints News

FDA's oncology head Rick Pazdur defends the accelerated approval pathway, claiming it is 'under attack'

4 years ago

To fill African manufacturing void, BioNTech will piggyback off plans for malaria mRNA vaccine with new manufacturing ...

4 years ago

In a win for struggling nations' vaccine supply, first African-produced doses of J&J shot hit arms

4 years ago

Thermo Fisher continues its hot streak, but a dip in diagnostics sales could be trouble

4 years ago

Charles River to expand Ireland manufacturing site to add Covid-19 vaccine capacity

4 years ago

Takeda doubles down at California site as it looks to grow rare disease manufacturing base

4 years ago

Roche nabs priority review for Eylea competitor; Italy's Angelini eyes CNS, rare disease startups with $35M Lumira ...

4 years ago

Three more companies price IPOs, bringing this year's raise up to $11.78B

4 years ago

A tale of two vaccines: AstraZeneca's shot still a blockbuster, but Pfizer sales are on another level

4 years ago

What made GlaxoSmithKline’s Hal Barron spend $2.2B to get back into neuro? Alector flashes the data

4 years ago

Resilience shells out $110M for bluebird bio site, kickstarting new collaboration

4 years ago

After a months-long halt on production, Emergent is back up and running in Baltimore

4 years ago

Covid-19 manufacturing roundup: Top diplomat calls for low-cost, overseas production of shots; Vietnam inks deal for ...

4 years ago

Covid-19 roundup: Eli Lilly's RA drug gets solo OK from FDA; Emergent gets greenlight to resume manufacturing at ...

4 years ago

As leading synbio players bask in spotlight, US/China startup lands $100M to find its own niche

4 years ago

Eli Lilly teams up with KRAS drug pioneer Yi Liu targeting small molecule I/O with $70M upfront

4 years ago

AstraZeneca and Amgen quietly admit tezepelumab setback as the Dupixent challenger heads to FDA

4 years ago

Flush with cash, Rakuten billionaire Mickey Mikitani looks to take his photoimmunotherapy platform global

4 years ago

Insulin biosimilar wins first-ever interchangeable designation from FDA

4 years ago

Merck and Pfizer back a Michigan startup's mission to advance tumor profiling

4 years ago

Alzheimer's adcomm members question FDA: How can you use amyloid as the basis for an accelerated approval?

4 years ago

When a life-saving vaccine became a cash cow: Pfizer now projects $33.5B in Covid-19 vaccine sales in 2021 alone

4 years ago

US sells Wu-Tang Clan album to cover Shkreli debt; OrbiMed backs GSK vets' Chinese startup

4 years ago

Bristol Myers' Opdivo turns the boat around in Q2 as manufacturing issues haunt CAR-T launch

4 years ago

First page Previous page 659 660 661662663 664 665 Next page Last page